Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome
- PMID: 16773616
- DOI: 10.1002/mds.21001
Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome
Abstract
There is no established treatment for the neurological features of the recently discovered fragile X-associated tremor/ataxia syndrome (FXTAS). Fifty-six patients with FXTAS completed a questionnaire to determine whether any medications had been effective for neurological symptoms. Of 11 subjects with definite FXTAS, 8 (70%) were on medications for their neurological symptoms, whereas most subjects with possible or probable FXTAS, 31 (70%) of 45 subjects, were not on medications. Although no therapy was uniformly effective for intention tremor, ataxia, Parkinsonism, memory loss, or anxiety, some subjects with intention tremor or Parkinsonism reported improvement with medications frequently used in other movement disorders. Overall, all 22 subjects on medications reported improvement in one or more symptoms. Lack of insight, recall bias, and cognitive impairment may have resulted in an underestimation of the beneficial effect of medical therapy. This study suggests that patients with FXTAS can derive improvement from medication treatment for some of their symptoms.
Similar articles
-
Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited.Parkinsonism Relat Disord. 2014 Apr;20(4):456-9. doi: 10.1016/j.parkreldis.2014.01.006. Epub 2014 Jan 18. Parkinsonism Relat Disord. 2014. PMID: 24491663 Free PMC article.
-
Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.JAMA. 2004 Jan 28;291(4):460-9. doi: 10.1001/jama.291.4.460. JAMA. 2004. PMID: 14747503
-
Fragile X-associated tremor/ataxia syndrome.Tidsskr Nor Laegeforen. 2017 Oct 30;137(20). doi: 10.4045/tidsskr.17.0317. Print 2017 Oct 31. Tidsskr Nor Laegeforen. 2017. PMID: 29094559 Review. English, Norwegian.
-
Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study.Neuropsychopharmacology. 2014 Nov;39(12):2760-8. doi: 10.1038/npp.2014.122. Epub 2014 May 29. Neuropsychopharmacology. 2014. PMID: 24871547 Free PMC article. Clinical Trial.
-
A Chinese case of fragile X-associated tremor/ataxia syndrome (FXTAS) with orthostatic tremor:case report and literature review on tremor in FXTAS.BMC Neurol. 2020 Apr 20;20(1):145. doi: 10.1186/s12883-020-01726-z. BMC Neurol. 2020. PMID: 32312236 Free PMC article. Review.
Cited by
-
Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation.Cells. 2023 Sep 21;12(18):2330. doi: 10.3390/cells12182330. Cells. 2023. PMID: 37759552 Free PMC article. Review.
-
Mouse models of fragile X-related disorders.Dis Model Mech. 2023 Feb 1;16(2):dmm049485. doi: 10.1242/dmm.049485. Epub 2023 Jan 24. Dis Model Mech. 2023. PMID: 36692473 Free PMC article. Review.
-
Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach.Front Neurol. 2022 Sep 14;13:977380. doi: 10.3389/fneur.2022.977380. eCollection 2022. Front Neurol. 2022. PMID: 36188408 Free PMC article.
-
A Novel Clinical Phenotype of Fragile X-Associated Tremor/Ataxia Syndrome.Mov Disord Clin Pract. 2018 Jul 19;5(4):430-432. doi: 10.1002/mdc3.12637. eCollection 2018 Jul-Aug. Mov Disord Clin Pract. 2018. PMID: 30838296 Free PMC article. No abstract available.
-
[Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].Rev Neurol. 2019 Mar 1;68(5):199-206. doi: 10.33588/rn.6805.2018457. Rev Neurol. 2019. PMID: 30805918 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical